A study of mean platelet volume in acute ischemic stroke

Authors

  • Vivekanand Kamat Department of General Medicine, MR Medical College, Kalaburgi, Karnataka, India
  • Satish Kinagi Department of General Medicine, MR Medical College, Kalaburgi, Karnataka, India
  • Anilkumar Patil Department of Neurology, MR Medical College, Kalaburgi, Karnataka, India

DOI:

https://doi.org/10.18203/2349-3933.ijam20210266

Keywords:

Ischemic stroke, Mean platelet volume, Modified rankins scale, Stroke severity

Abstract

Background: A stroke is defined by the abrupt onset of neurological deficit that is attributable to a focal vascular cause. Because of the growth in the number of ageing population, the burden of stroke is likely to increase automatically in the coming future. Mean platelet volume (MPV), a marker of platelet function is a physiological variable of hemostatic importance. Changes in MPV play a more important role in hemostasis than platelet count. Very few studies has looked at the association between mean platelet volume and ischemic stroke. So, the objectives were to study mean platelet volume in acute ischemic stroke, the role of mean platelet volume as an independent risk factor in acute ischemic stroke and to study the association between MPV and outcome in patients with acute ischemic stroke.

Methods: A cross sectional analytical study was conducted on 60 patients with ischemic stroke identified based on clinical features and MRI of Brain admitted in Mahadevappa Rampure Medical College, Kalaburgi. Mean platelet volume (MPV) on admission was documented and severity of stroke at the presentation and at discharge was assessed using Modified Rankins scale (MRS).

Results: Among 60 patients, 40% of the study patients were aged between 60-80 years and 60% of study population were male and 40% female. The co-morbid conditions present were hypertension in 50%, diabetes mellitus in 41% .The MPV was raised (>12.5fl) in 64 %of the patients. The clinical severity of stroke at presentation as determined by the Modified Rankin‘s scale (MRS) were moderate (20%), moderately severe (35%) and severe disability in 36.7% of cases. In our study MPV showed statistically significant correlation with Ischemic stroke severity. Clinical outcome as assessed by comparing MRS at admission and discharge with presentation MPV showed 25% moderately, 30% moderately severe and 23% were severely disabled. However, no statistical significance was seen.

Conclusions: We conclude that MPV is raised in acute ischemic stroke and is an independent predictor of the risk of stroke. Higher MPV are associated with more severe stroke and tend to have poorer outcome. Mean platelet volume an indicator of platelet reactivity is a simple and easy test available in panel of hemogram and can serve as a valuable predictor of severity and outcome in acute ischemic stroke patients.

Author Biographies

Vivekanand Kamat, Department of General Medicine, MR Medical College, Kalaburgi, Karnataka, India

Post Graduate

Department of General Medicine 

M.R.Medical college,Kalaburgi

Satish Kinagi, Department of General Medicine, MR Medical College, Kalaburgi, Karnataka, India

Professor

Department of General Medicine 

M.R.Medical college,Kalaburgi

Anilkumar Patil, Department of Neurology, MR Medical College, Kalaburgi, Karnataka, India

Associate Professor

Department of Neurology

M.R.Medical College Kalaburgi

References

Smith WS, English JD, Johnston SC. Cerebrovascular diseases. Harrison‘s Principles of Internal Medicine. Ed. Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL et al. 20th edition. Mc Graw Hill. 2016:3068-3095,

Bath P, Algert C, Chapman N, Neal B. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular diseases. Stroke. 2004;35:622-6.

Martin JF, Towbridge A, eds. Platelet heterogeneity: Biological and Pathology. London, UK: Springer-Verlag. 1990.

Jakubowski JA, Thomson CB, Vaillancourt R, Valeri CR, Deykin D. Arachidonic acid metabolism by platelets of differing size. Br J Haematol. 1983;53:503-11.

Martin JF, Towbridge EA, Salmon G, Plumb J. The biological significance of platelet volume: Its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res. 1983;32:443-60.

Haver VM, Gear ARL. Functional fractionation of platelets. J Lab Clin Med. 1981;97:187-204.

Thomson CB, Jakubowski JA, Quinn PG, Deykin D, Valeri CR. Platelet size as a determinant of platelet function. J Lab Clin Med. 1981;97:187-204.

Frojmovic MM, Milton JG. Human platelet size, shape, and related functions in health and disease. Physiolog Rev. 1982;62(1):185-261.

Smith NM, Pathansali R, Bath PMW. Platelets and stroke. Vascular Med. 1999;4:165-72.

Dougherty JH, Levy DE, Weksler BB. Platelet activation in acute cerebral ischemia. Lancet. 1997;1:821-4.

Tohgi H, Suzuki H, Tamura K, Kimura B. Platelet volume, aggregation and ATP release in cerebral thrombosis. Stroke. 1991;22:17-21.

Mdlley TO, Langhorne P, Elton RA, Steward C. Platelet size in stroke patients. Stroke. 1995;26:995-9.

Erasmo ED, Aliberti G, Celi FS. Platlet count, mean platelet volume and their relationship to prognosis in cerebral infarction. J Int Med. 1990;227:11-4.

Butterworth RJ, Path PMW. The relationship between mean platelet volume, stroke subtypes and clinical outcome. Platelet. 1998;9:359-64.

Bath P, Algert C, Chapman V, Neal B. Association of MPV with risk of stroke among 3134 individuals with history of cerebrovascular diseases. Stroke. 2004;35(3):622-6.

Karepov VG, Gur AY. Stroke in evolution: infarct -inherent mechanisms versus systemic causes and other cerebrovascular disorders. Stroke. 2006;21:41-6.

Shah AB, Beamer N, Coull BM. Enhanced in vivo platelet activation in subtypes of ischemic stroke. Stroke. 1985;16:643-7.

Muscari S, Muscari A. The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. Int J Clin Pract. 2009;63:1509-15.

Pikija S, Trkulja V, Malojcic B, Mutzenbach JS, Sellner J. A high burden of ischemic stroke in regions of eastern/central europe is largely due to modifiable risk factors. Curr Neurovasc. 2015;12(4):341-52.

Bath P, Algert C, Chapman N, Neal B. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular diseases. Stroke. 2004;35:622-6.

Sadeghi F, Kovács S, Zsóri KS, Csiki Z, Bereczky Z, Shemirani AH. Platelet count and mean volume in acute stroke: a systematic review and meta-analysis, Platelets. Br J Haematol. 2020;31(6):731-9.

Patil P, Darshan A, Ao S, Kothiwale VA. Association of mean platelet volume with acute ischemic cerebrovascular accident among patients with type 2 diabetes mellitus: a hospital-based study. J Assoc Physicians India. 2018;66(8):44-7.

Meena P. A study of platelet indices in patients of acute ischemic stroke: a prospective study. IOSR J Dental Med Sci. 2017;16(8):26-9.

Ghahremanfard F, Asghari N, Ghorbani R, Smaei A, Ghomi H, Tamadon M. The relationship between mean platelet volume and severity of acute ischemic brain stroke. Neurosci. 2013;18(2):147-51.

Greisengger S, Endler G, Hsieh K, Tentschert S, Mannhalter C, Lalouschek W. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular event? Stroke. 2004;35:1688.

Mohamed AB, Elnady HM, Alhewaig HK, Moslem Hefny H, Khodery A. The mean platelet volume and plateletcrit as predictors of short-term outcome of acute ischemic stroke. Egypt J Neurol Psychiatr Neurosurg. 2019;55(1):4.

Staszewski J, Pogoda A, Data K. The mean platelet volume on admission predicts unfavourable stroke outcomes in patients treated with IV thrombolysis. Clin Interv Aging. 2019;14:493-503.

Downloads

Published

2021-01-27

Issue

Section

Original Research Articles